Raxofelast (IRFI 016): A new hydrophilic vitamin E-like antioxidant agent

Cardiovascular Drug Reviews

Volumn 15, Issue 2, 1997, Pages 157-173

  Campo, Giuseppe M ^a,c   Ceccarelli, Stefano ^b   Squadrito, Francesco ^a   Altavilla, Domenica ^a   Dorigotti, Luciano ^b   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Biomedica Foscama Research Center   (Italy)

^c School of Legal Medicine   (Italy)

Author keywords

Antioxidant; Free radicals; IRFI 016; Lipid peroxidation; Myocardial ischemia; Raxofelast

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ANTIOXIDANT; IRFI 005; RAXOFELAST; RAXOFLEST; SUPEROXIDE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; CHEMISTRY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TOXICITY; DRUG TRANSFORMATION; HEADACHE; HEART MUSCLE ISCHEMIA; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MUTAGENICITY; NEUTROPHIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REPRODUCTION; REVIEW; STOICHIOMETRY;

EID: 0030768269     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.1997.tb00329.x     Document Type: Review

References (40)

1. Aoki N, Bitterman H, Brenzinski ME, Lefer AM. Cardioprotective actions of human superoxide dismutase in two reperfusion models of myocardial ischaemia in the rat. Br J Pharmacol 1988;95:735-740.
2. Bernheirn F, Bernheim MLC, Wilbur KM. The reaction between thiobarbituric acid and the oxidation products of certain lipides. J Biol Chem 1948;174:257-264.
3. Bianco T, Centore R, Giannetti P, Scuri R. Compared kinetics of 2-(2,3-dihydro-5-acetoxy-4,6,7-trimethylbenzofuranyl)acetic acid (IRFI 016) and its active metabolite 2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl)acetic acid (IRFI 005) in plasma and bronchial alveolar liquid in mice. Drugs Exp Clin Res 1992;18:93-97.
4. Bindoli A, Rigobello MP, Musacchio E, Scuri R, Rizzoli V, Galzigna L. Protective action of a new benzofuran derivative on lipid peroxidation and sulphydryl groups oxidation. Pharmacol Res 1991;24:369-375.
5. Borregard N. The respiratory burst: An overview. In: Sharma AJ, Strauss PR, eds. The Respiratory Burst and its Physiological Significance. New York: Plenum, 1989:1-31.
6. Brigham KL. Role of free radicals in lung injury. Chest 1986;89:859-863.
7. Burton GW, Doba T, Gabe EJ, et al. Autoxidation of biological molecules. Maximizing the antioxidant activity of phenols. J Am Chem Soc 1985;107:7053-7065.
8. Burton GW, Hughes L, Ingold KU. Antioxidant activity of phenols related to vitamin E. Are there chain-breaking antioxidants better than α-tocopherol? J Am Chem Soc 1983;105:5950-5951.
9. Calapai G, Squadrito F, Rizzo A, et al. A new antioxidant drug limits brain damage induced by transient cerebral ischaemia. Drugs Exp Clin Res 1993;19:159-164.
10. Campo GM, Ioculano M, Avenoso A, Pollicino MA, Calandra S. Effetto protettivo dell'IRFI 016, un nuovo composto antiossidante, sul danno miocardico da ischemia e riperfusione nel ratto. Atti Acc Pelor Per 1991;29:177-194.
11. Campo GM, Squadrito F, Ioculano M, et al. IRFI 016, a new radical scavenger, limits ischemic damage following coronary artery occlusion in rats. Res Commun Chem Pathol Pharmacol 1992;76:287-303.
12. Campo GM, Squadrito F, Ioculano M, et al. Protective effects of IRFI016, a new antioxidant agent, in myocardial damage following coronary artery occlusion and reperfusion in the rat. Pharmacology 1994; 48:157-166.
13. Ceccarelli S, De Vellis P, Scuri R, Zanarella S. Synthesis of novel 2-substituted-5-oxycoumarans via a direct route to 2,3-dihydro-5-hydroxy-2-benzofuranacetic acids. J Heterocycl Chem 1993;30:679-690.
14. Centore R, Bianco T, Ceccarelli S, Dorigotti L. Pharmacokinetic profile of raxofelast, a novel antioxidant agent chemically related to alpha-tocopherol. Pharmacol Res (Suppl.) 1995;31:38.
15. Del Maestro RF. An approach to free radicals in medicine and biology. Acta Physiol Scand 1980;492:153-168.
16. Downey JM, Omar B, Ooiwa H, McCord J. Superoxide dismutase therapy for myocardial ischaemia. Free Rad Res Commun 1991;12:703-720.
17. Fabbs CF, Cregor MD, Badylak SF. Histochemical demonstration of endothelial Superoxide and hydrogen peroxide generation in ischaemic and reoxygenated rat tissue. Cardiovasc Res 1992;26:593-602.
18. Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 1990;4:2587-2597.
19. Hall ED, Braughler JM, Yonkers PA, et al. U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J Pharmacol Exp Ther 1991;258:688-694.
20. Halliwell B. How to characterize a biological antioxidant. Free Rad Biol Med 1990;9:1-32.
21. 6. Am J Clin Nutr 1986;44:973-982.
22. Nunes FA, Kumar C, Change B, Brass CA. Chemiluminescent measurement of increased free radicals formation after ischemia/reperfusion in liver. Dig Dis Sci 1995;40:1045-1053.
23. Jolly S, Kane WJ, Baile MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury: its reduction by the combined administration of Superoxide dismutase and catalase. Circ Res 1984;54:277-285.
24. Kehrer JP, Mossman BT, Sevanian A, Trush MA, Smith MT. Free radical mechanisms in pathogenesis. Toxicol Appl Pharmacol 1988;95:349-362.
25. Mattoli S, Mezzetti M, Allegra L, Braga PC. Dihydro-hydroxy-trimethyl-benzofuranyl acetic acid inhibits lipid peroxidation and lysosomal enzyme release in bronchial epithelial cells and macrophages. Ital J Chest Dis 1991;45:78-80.
26. McCord JM. The superoxide free radical: Its biochemistry and pathophysiology. Surgery 1983;94:412-414.
27. Milly K, Wit L, Diskin C, Tulley R. Selenium in renal failure patients. Nephron 1992;61:139-144.
28. Myers CL, Weiss SJ, Kirsh MM, Shepard BM, Shlafer M. Effects of supplementing hypothermie crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol or deferoxamine on functional recovery of globally ischaemic and reperfused isolated hearts. J Thorac Cardiovasc Surg 1986;91:281-289.
29. Ohkawa S, Fukatsu K, Miki S, et al. 5-Aminocoumarans: Dual inhibitors of lipid peroxidation and dopamine release with protective effects against central nervous system trauma and ischemia. J Med Chem 1997;40: 559-573.
30. Petty MA, Dow J, Grisar JM, De Jong W. Effect of a cardioselective α-tocopherol analogue on reperfusion injury in rats induced by myocardial ischemia. Eur J Pharmacol 1991;192:383-388.
31. Rimm EB, Stampfer MJ, Ascherio A. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
32. Scuri R, Giannetti P, Paesano A. 2-(2,3-Dihydro-5-acetoxy-4,6,7-trimethylbenzofuranyl) acetic acid (IRFI 016): A new antioxidant mucoactive drug. Drugs Exp Clin Res 1990;16:649-656.
33. Stampfer MJ, Hennekens CH, Manson JE. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 1993;328:1444-1449.
34. Thomas MJ, Bielski BHJ. Oxidation and reaction of Trolox C, a tocopherol analogue, in aqueous solution: A pulse-radiolysis study. J Am Chem Soc 1989;111:3315-3319.
35. Urso R, Moltoni L, Billarelli C, Segre G. Pharmacokinetics of IRFI 016 and IRFI 005 in rats. Pharmacol Res (Suppl. 1) 1992;26:265.
36. Van Gossum A, Kurian R, Whitwell J, Jeejeebhoy KN. Decrease in lipid peroxidation measured by breath pentane output in normals after oral supplementation with vitamin E. Clin Nutr 1988;7:53-57.
37. Viglianti B, Ceccareilli S, Dorigotti L. Characterization of in vitro redox interactions of the antioxidant raxofelast and its metabolites with red blood cells. To be presented at the First Italian-Swiss Meeting on Medicinal Chemistry, Sept 23-26, 1997, Turin, Italy.
38. Vliet AVD, Bast A. Role of reactive oxygen species in intestinal diseases. Free Rad Biol Med 1992;12: 499-513.
39. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
40. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. J Biol Chem 1988; 263:1353-1357.